671 related articles for article (PubMed ID: 23159075)
21. Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
Zhao XY; Yang S; Chen YR; Li PC; Dou MM; Zhang J
PLoS One; 2014; 9(6):e98925. PubMed ID: 24901647
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer.
Wang CX; Koay DC; Edwards A; Lu Z; Mor G; Ocal IT; Digiovanna MP
Breast Cancer Res Treat; 2005 Aug; 92(3):251-63. PubMed ID: 16155796
[TBL] [Abstract][Full Text] [Related]
23. Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells.
Wang Y; Wang L; Yin C; An B; Hao Y; Wei T; Li L; Song G
Mol Med Rep; 2015 Jul; 12(1):1233-8. PubMed ID: 25824027
[TBL] [Abstract][Full Text] [Related]
24. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
25. [Re-expression of p16 gene in myeloma cell line U266 by arsenic trioxide].
Li JQ; Li Y; Shi YJ; Wu SL
Ai Zheng; 2004 Jun; 23(6):626-30. PubMed ID: 15191659
[TBL] [Abstract][Full Text] [Related]
26. [As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells].
Yang L; Luo JM; Li Y; Liu XJ; Wen SP; Du XY; Yao L; Yang JC; Dong ZR
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):423-7. PubMed ID: 19950550
[TBL] [Abstract][Full Text] [Related]
27. [Primary research on arsenic trioxide inhibiting human breast cancer cells growth and its mechanisms].
Wei L; Wang XW; Zuo WS; Song XR
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1209-13. PubMed ID: 16029599
[TBL] [Abstract][Full Text] [Related]
28. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
29. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.
Xiao YF; Wu DD; Liu SX; Chen X; Ren LF
World J Gastroenterol; 2007 Dec; 13(48):6498-505. PubMed ID: 18161919
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.
Wang L; Hu X; Xu Y; Liu Z
Tumour Biol; 2016 Nov; 37(11):15165-15173. PubMed ID: 27677289
[TBL] [Abstract][Full Text] [Related]
31. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
Zhang B; Zhang X; Tang B; Zheng P; Zhang Y
Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650
[TBL] [Abstract][Full Text] [Related]
32. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.
Fan J; Yin WJ; Lu JS; Wang L; Wu J; Wu FY; Di GH; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2008 Aug; 134(8):883-90. PubMed ID: 18264725
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
34. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
[TBL] [Abstract][Full Text] [Related]
35. [Synergistic effects of VPA and As2O3 on Molt-4 cells in vitro and its possible mechanisms].
Ye BG; Lin FA; Shen JZ; Fan LP; Lin CM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1288-92. PubMed ID: 19099629
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression.
Zhang X; Zhang B; Liu J; Liu J; Li C; Dong W; Fang S; Li M; Song B; Tang B; Wang Z; Zhang Y
Sci Rep; 2015 Feb; 5():7835. PubMed ID: 25644501
[TBL] [Abstract][Full Text] [Related]
37. Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.
Chen J; Saggar JK; Corey P; Thompson LU
Br J Nutr; 2011 Feb; 105(3):339-47. PubMed ID: 21138602
[TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
39. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
40. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
Perez White B; Molloy ME; Zhao H; Zhang Y; Tonetti DA
Mol Cancer; 2013 May; 12():34. PubMed ID: 23634843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
